🇺🇸 Alprolix in United States

1,808 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Haemorrhage — 836 reports (46.24%)
  2. Haemarthrosis — 193 reports (10.67%)
  3. Fall — 149 reports (8.24%)
  4. Contusion — 114 reports (6.31%)
  5. Arthralgia — 106 reports (5.86%)
  6. Traumatic Haemorrhage — 101 reports (5.59%)
  7. Limb Injury — 87 reports (4.81%)
  8. Epistaxis — 77 reports (4.26%)
  9. Head Injury — 73 reports (4.04%)
  10. Spontaneous Haemorrhage — 72 reports (3.98%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Alprolix approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Alprolix in United States?

Swedish Orphan Biovitrum is the originator. The local marketing authorisation holder may differ — check the official source linked above.